Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB Notes Newsletter

(PDF - 1MB)

No. 1, 2012

NEW CDC PUBLICATIONS

Alexy ER, Podewils LJ, Mitnick CD, Becerra MC, Laserson KF, Bonilla C. Concordance of programmatic and laboratory-based multidrug-resistant tuberculosis treatment outcomes in Peru. The International Journal of Tuberculosis and Lung Disease 2012 March 1; 16 (3): 364-369.

Angra PK, Taylor TH, Iademarco MF, Metchock B, Astles JR, and Ridderhof JC. Performance of tuberculosis drug susceptibility testing in the United States laboratories 1994–2008. J Clin Microbiol. 2012 Feb 1. [Epub ahead of print.]

Barry PM, Gardner TJ, Funk E, Oren E, Field K, Shaw T, et al. Multistate outbreak of MDR TB identified by genotype cluster investigation. Emerg Infect Dis [serial on the Internet]. 2012 Jan. http://dx.doi.org/10.3201/eid1801.110671.

Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE, for the TB Trials Consortium. Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment. Int J Tuberc Lung Dis 2012 Feb 8 [e-pub ahead of print].

Click ES, Moonan PK, Winston CA, Cowan LS, Oeltmann JE. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. CID 2012; 54 (2): 211-9.

Finlay A, Lancaster J, Holtz TH, Weyer K, Miranda A, van der Walt M. Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study. BMC Public Health 2012; 12:56; doi:10.1186/1471-2458-12-56. Available at http://www.biomedcentral.com/1471-2458/12/56.

Hill AN, Becerra JE, Castro KG. Modelling tuberculosis trends in the USA. Epidemiology and Infection 2012. Published online Jan. 11, 2012; doi:10.1017/S095026881100286X.

Jereb JA, Privett TD, Pearson ML. Tuberculin skin test conversions in hospital housekeepers. [Correspondence.] The International Journal of Tuberculosis and Lung Disease 2012 Feb 1; 16 (2): 279.

Kalokhe AS, Shafiq M, Lee JC, Metchock B, Posey JE, Ray SM, Anderson A, Wang YF, Nguyen ML. Discordance in Mycobacterium tuberculosis rifampin susceptibility. [Letter.] Emerg Infect Dis 2012;18:537-9. Online: http://dx.doi.org/10.3201/eid1803.111357.

Kittikraisak W, Kingkaew P, Teerawattananon Y, Yothasamut J, Natesuwan S, Manosuthi W, Chongsuvivatwong V, Whitehead SJ. Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS ONE 2012; 7(1): e29775. doi:10.1371/journal.pone.0029775.

Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs. [Short communication.] The International Journal of Tuberculosis and Lung Disease 2012 March 1; 16 (3): 355-357.

Moonan PK, Ghosh S, Oeltmann JE, Kammerer JS, Cowan LS, Navin TR. Using genotyping and geospatial scanning to estimate recent Mycobacterium tuberculosis transmission, United States. Emerg Infect Dis [serial on the Internet]. 2012 Mar; 18 (3): 458-465. http://dx.doi.org/10.3201/eid1803.111107.

Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. [Short communication.] The International Journal of Tuberculosis and Lung Disease 2012 Feb 1; 16 (2): 203-205.

Vernon AA and Villarino ME. Reinfection redux. [Editorial Commentary.] Clin Infect Dis 2012. Published online Jan. 19, 2012; doi:10.1093/cid/cir947.

Top of Page

 

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #